(Q43001302)

English

Impact of amino acid substitutions in hepatitis C virus genotype 1b core region on liver steatosis and glucose tolerance in non-cirrhotic patients without overt diabetes

scientific article published in May 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Impact of amino acid substitutions in hepatitis C virus genotype 1b core region on liver steatosis and glucose tolerance in non-cirrhotic patients without overt diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

liver cirrhosis

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Toshikazu Yoshikawa

11

object named as

Toshikazu Yoshikawa

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Yoshio Sumida

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kazuyuki Kanemasa

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tasuku Hara

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yutaka Inada

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kyoko Sakai

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Shunsuke Imai

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Naohisa Yoshida

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kohichiroh Yasui

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yoshito Itoh

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Takeshi Okanoue

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

836-842

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

The importance of steatosis in chronic hepatitis C infection and its management: A review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Steatosis and intrahepatic hepatitis C virus in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Association of diabetes mellitus and chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Hepatitis C virus infection can present with metabolic disease by inducing insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Steatosis: co-factor in other liver diseases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Critical role of PA28 in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Specific Polymorphisms in Hepatitis C Virus Genotype 3 Core Protein Associated with Intracellular Lipid Accumulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Hepatitis C virus-induced steatosis: an overview

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Impact of amino acid substitutions in the core region of HCV on multistep hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Novel insulin sensitivity index derived from oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Role of ChREBP in hepatic steatosis and insulin resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06568.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2010.06568.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43001302&oldid=1976342309"